Resverlogix - CEO, Donald McCaffrey.

" Resverlogix (TSX:RVX) in discussions for COVID-19 clinical studies in Morocco

Resverlogix (RVX) is in discussions to launch Phase 2 COVID-19 clinical studies with Apabetalone in Morocco.